Sanofi’s vaccines division -- Sanofi Pasteur -- has launched ShanIPV, an injectable inactivated polio vaccine (IPV) manufactured by its arm Shantha Biotechnics in Hyderabad.
ShanIPV is a ‘made in India’ vaccine, manufactured in Hyderabad through technology transfer from Sanofi Pasteur. It is currently approved for use in the Indian market.
Both Sanofi Pasteur and its affiliate Shantha will provide the majority of vaccine doses needed till the end of 2016. All vaccines (both Imovax Polio of Sanofi Pasteur and ShanIPV of Shantha) will be delivered to India through UNICEF.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
